Could a sleep apnea machine keep heart patients out of the hospital?

NCT ID NCT03647891

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study investigates whether diagnosing and treating obstructive sleep apnea with CPAP therapy early, while patients are still in the hospital for heart problems, can reduce the chance of being readmitted within 30 days. The trial enrolls adults with heart failure, heart attack, or arrhythmia who also have sleep apnea. Participants receive CPAP, a device that keeps the airway open during sleep, and researchers track readmission rates and other health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Continuous Positive Airway Pressure (CPAP) therapy
What this could lead to
If successful, early CPAP treatment could become a standard part of cardiac care to prevent hospital readmissions.
What could go wrong
This is a small, early-stage study without a control group, so results may not be conclusive. CPAP adherence can be low, which may limit its impact.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sleep Center; San Bernardino County Medical Center, Kaiser Permanente

    Fontana, California, 92335, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.